NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.35% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 14.29% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 8.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 7.10% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 1.61% |
| 10 | NovoCure | 1.97 Bn | 1.53 Bn | 142.48 Mn | -6.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.18% |
| Mar 31, 2026 | -4.17% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | 9.18% |
| Jun 30, 2025 | 20.84% |
| Mar 31, 2025 | 35.10% |
| Dec 31, 2024 | 50.86% |
| Sep 30, 2024 | 60.77% |
| Jun 30, 2024 | 61.52% |
| Mar 31, 2024 | 61.62% |
| Dec 31, 2023 | 57.53% |
| Sep 30, 2023 | 53.18% |
| Jun 30, 2023 | 54.95% |
| Mar 31, 2023 | 45.40% |
| Dec 31, 2022 | 44.00% |
| Sep 30, 2022 | 154.25% |
| Jun 30, 2022 | 124.01% |
| Mar 31, 2022 | 113.69% |
| Dec 31, 2021 | 99.15% |
| Sep 30, 2021 | 13.90% |